Monday 18 March 2024

This Mutation Likely Saved a Colon Cancer Patient's Life

photo of combination chemo and immunotherapy

His tumor had a specific genetic makeup known as mismatch repair-deficient, present in 5% to 10% of all rectal cancer patients, meaning he might qualify for a cutting-edge immunotherapy.



from WebMD Health https://ift.tt/DqZr5sj

0 comments:

Post a Comment